MedPath

Improving mental health care for unaccompanied young refugees through a stepped care approach

Not Applicable
Recruiting
Conditions
Post-traumatic stress disorder
DSM-5: Posttraumatic Stress Disorder
F43.1
Registration Number
DRKS00017453
Lead Sponsor
Katholische Universität Eichstätt-Ingolstadt
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
540
Inclusion Criteria

Inclusion criteria for this study are two-fold.

A) At the level of the participating facilities (i.e., residential groups where UYRs are residing)
1) At least 5 UYRs residing in the facility at intake, 2) Willingness to training and implementation of the screening, 3) Willingness to appoint a mental health coordinator within the facility, 4) Willingness to implement ‘Mein Weg’ within the facility, 5) In case of referral of UYRs to TF-CBT, willingness to send a caregiver for participation in TF-CBT, 6) At least one eligible therapist per 10 UYRs available in the vicinity (not more than 1 hour travel time) or at least one eligible therapist assigned to the facility who is willing to conduct online treatment.

B) At the level of the participating UYRs:
1) Age 12 to 20 years, 2) Unaccompanied, 3) Applied for asylum in Germany or planning on doing so, 4) Living in residential care provided by a facility of the Child and Youth Welfare System (CYWS), 5) Informed consent given (by UYRs and legal guardians in case of minors), 6) Report of at least one traumatic experience in the initial screening (CATS-2).

Exclusion Criteria

At the level of CYWS facilities:

1) No previous participation in Mein Weg studies (Pfeiffer & Goldbeck, 2017; Pfeiffer et al., 2018).

There are no exclusion criteria at the level of the participating UYRs.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of PTSS, assessed with the Child and Adolescent Trauma Screen 2 (CATS-2), 12 months after randomization.
Secondary Outcome Measures
NameTimeMethod
1) Severity of depressive symptoms, assessed with the Patient Health Questionnaire (PHQ-9), 12 months after randomization.<br>2) Severity of anxiety symptoms, assessed with the Generalized Anxiety Disorder (GAD-7), 12 months after randomization.<br>3) Quality of life, assessed with the World Health Organization Quality of Life, brief version (WHOQOL-BREF), 12 months after randomization.<br>4) Severity of PTSS, assessed with the CAT-2 caregiver report, 12 months after randomization.
© Copyright 2025. All Rights Reserved by MedPath